UnityPoint Health-Grinnell has introduced the Neoprobe Gamma Detection System technology by Mammotome for breast cancer diagnosis and treatment. Anna Mensing, a general and breast surgeon at Grinnell General Surgery and Weight Loss Surgery Clinic, is now using Neoprobe in surgery to provide patients with a more accurate and personalized approach to their breast cancer care. Neoprobe is an imaging device that helps surgeons pinpoint cancerous tissue during surgery, offering a clearer picture of affected tissue tumors for improved diagnosis and treatment planning.
This innovative technology provides enhanced accuracy, allowing for a more precise and less invasive surgery, potentially reducing complications and improving patient outcomes. It also allows for a more personalized treatment plan tailored to each patient’s specific needs. UnityPoint Health-Grinnell aims to offer local access to cutting-edge care by providing Neoprobe technology locally. This enables patients to receive advanced care close to home, reducing stress and travel burdens.
If you want to learn more about Neoprobe technology and how it can benefit breast cancer patients, you can speak with a primary care provider or contact the UnityPoint Health-Grinnell General Surgery and Weight Loss Surgery Clinic at 641-236-4323. This new technology brings advanced care to patients in the Grinnell area, ensuring that they receive the best possible treatment for their breast cancer diagnosis.